UNSPSC 51343101: Idoxuridine

This classification denotes a pyrimidine antagonist and antiviral agent with the molecular formula C9H11IN2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LGP81V5245, chemically known as uridine, 5-iodo-2-deoxy- but generally known as idoxuridine, which bears US NIH Compound Identifier 3687. European Medicines Agency schedules Idoxuridine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08117MIG.

UNSPSC 51343101 Idoxuridine is a Commodity code that in recent state and local solicitations encompasses a broader range of pharmaceutical and medical supply procurement than its specific product name suggests. State and local governments are using this code to solicit naloxone and drug deactivation systems, generic pharmaceuticals and over-the-counter products through multi-state cooperative purchasing, direct-to-manufacturer prescription programs, and medical and first aid supplies for emergency response operations. The issuing bodies include county health departments, state health and human services commissions, city purchasing departments, and regional cooperative purchasing alliances administering multi-jurisdictional programs. Scope varies from specialized pharmaceutical sourcing with manufacturer direct relationships to high-volume consumable supplies for fire rescue operations, reflecting the flexibility of the code's application across different procurement models within the pharmaceutical and medical supply category.

Recent activity spans multiple states with concentration in Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023; the Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program; the City of Tampa issued IFB 26P00145 for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division by March 13, 2026 with an estimated contract value of $700,000.00 and a Small Local Business Enterprise set-aside; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026, serving Minnesota, Oregon, and participating state and local government facilities through authorized wholesalers. Cooperative purchasing vehicles appear frequently, with MMCAP representing a multi-state model aggregating demand across public entities.